American Medical Systems (AMS) has signed a co-development agreement with Allergan, a big multi- specialty pharma company to jointly develop and seek regulatory approval for the delivery of BOTOX (onabotulinumtoxinA) using the JetTouch system for treatment of overactive bladder (OAB).
AMS will first develop JetTouch(TM) for general use in the bladder.
Subject to the FDA approval of BOTOX for injection by needle as a treatment for OAB, AMS, in collaboration with Allergan, will seek to add BOTOX to the JetTouch label, and Allergan plans to seek regulatory advice to add the delivery of BOTOX with JetTouch to the BOTOX label.
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity